Trial intelligence / Profile preview

Oral montelukast in the treatment of acute asthma in children

IRCT20200412047048N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Apr 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of montelukast in asthma, sponsored by Tehran University of Medical Sciences. Started Apr 2018; status: completed.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on IRCT20200412047048N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200412047048N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call